Computational design of immunogenic peptide–ligand conjugates for targeted therapy against Nipah virus infection
Introduction Nipah virus (NiV) poses a major risk to global public health due to its high infectivity and associated mortality rates. Currently, no licensed vaccines or antiviral medications are available for NiV infection, leaving clinical management limited to supportive care. The viral receptor glycoprotein responsi...